Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
2.53B
-
Number of holders
-
3266
-
Total 13F shares, excl. options
-
1.96B
-
Shares change
-
+19.9M
-
Total reported value, excl. options
-
$155B
-
Value change
-
+$1.46B
-
Put/Call ratio
-
0.99
-
Number of buys
-
1407
-
Number of sells
-
-1768
-
Price
-
$79.16
Significant Holders of Merck & Co., Inc. - Common Stock (MRK) as of Q2 2025
3,634 filings reported holding MRK - Merck & Co., Inc. - Common Stock as of Q2 2025.
Merck & Co., Inc. - Common Stock (MRK) has 3,266 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.96B shares
of 2.53B outstanding shares and own 77.47% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (253M shares), BlackRock, Inc. (218M shares), STATE STREET CORP (118M shares), WELLINGTON MANAGEMENT GROUP LLP (76.9M shares), GEODE CAPITAL MANAGEMENT, LLC (59M shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (53.9M shares), MORGAN STANLEY (44.2M shares), NORGES BANK (36.1M shares), JPMORGAN CHASE & CO (31.8M shares), and FMR LLC (31.6M shares).
This table shows the top 3266 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.